The civic record
Read. Follow. Verify.Senate Hearing on the Future of Precision Medicine
Record date · January 1, 2017
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Does
The Senate Committee on Health, Education, Labor, and Pensions held a hearing on May 5, 2015, to discuss the development and implementation of . The hearing explored how tailoring medical treatments to an individual's genetic makeup can improve patient outcomes, particularly in areas like diabetes and cancer treatment.
This hearing established the legislative foundation for federal support and regulatory frameworks for , which aims to shift healthcare from generalized treatments to personalized therapies based on individual DNA.
Who It Affects
Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.
Patients with genetic-based diseases
These individuals may receive personalized treatment plans based on their specific genetic mutations.
Medical research institutions
These organizations are involved in the development and application of genetic sequencing and precision therapies.
Key Facts
- The hearing took place on May 5, 2015, in the Dirksen Senate Office Building.
- Precision medicine involves using an individual's DNA and genetic makeup to tailor medical treatments.
- The committee discussed the use of genetic sequencing to treat specific mutations in cancer cells.
- Major cancer centers like Sloan-Kettering, Dana-Farber, and MD Anderson have begun automatically sequencing tumors for incoming patients.
Show all 5 facts
- The hearing included testimony from the NIH, the Office of the National Coordinator for Health Information Technology, and the FDA.
Frequently Asked Questions
What is precision medicine?
Why is the Senate discussing this?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceFull breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Shift toward personalized medicine
The hearing marks a formal legislative interest in moving away from generalized disease treatment toward genetic-based personalized medicine.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance65How much this matters to a regular citizen
- Controversy10Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz15Current news / social attention level
Publisher tools